Use of intravenous immunoglobulin in chronic lymphocytic leukemia. A brief review.
Chronic lymphocytic leukemia (CLL) is a disorder with multiple defects leading to an increased susceptibility to infection. Hypogammaglobulinemia is present in about 20% to 70% of patients with CLL. Intravenous immunoglobulin (IVIG) supplementation (400 mg/kg body weight every 3 weeks) prevented bac...
Main Authors: | Dicato, M, Chapel, H, Gamm, H, Lee, M, Ries, F, Marichal, S, Wirth, C, Griffith, H, Brennan, V |
---|---|
Format: | Conference item |
Izdano: |
1991
|
Podobne knjige/članki
-
Intravenous immune globulin in chronic lymphocytic leukaemia.
od: Gamm, H, et al.
Izdano: (1994) -
Immunoglobulin replacement in patients with chronic lymphocytic leukaemia: a comparison of two dose regimes.
od: Chapel, H, et al.
Izdano: (1994) -
Intravenous immunoglobulin for the prevention of infection in chronic lymphocytic leukemia. A randomized, controlled clinical trial. Cooperative Group for the Study of Immunoglobulin in Chronic Lymphocytic Leukemia.
od: Gamm, H, et al.
Izdano: (1988) -
Home intravenous immunoglobulin therapy.
od: Chapel, H, et al.
Izdano: (1988) -
Intravenous immunoglobulin therapy.
od: Chapel, H
Izdano: (1996)